Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

VIDA VHIO International postDoctoral programme for translAtional research

Coordinator
Fundacio Privada Institut D'investigacio Oncologica De Vall-Hebron (vhio), Spain
Runs
1 January 2025 to 30 June 2030
Status
Running
EU funding
€1.7m
Total cost
—
Partners
17 organisations in 6 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101179122

What the project is doing

In the project's own words, from its summary on CORDIS.

The proposed “VHIO International postDoctoral programme for translAtional research” (VIDA) aims at enabling outstanding junior scientists of all nationalities to develop a competitive research project at VHIO, an international reference center for personalized medicine in oncology that thanks to its pioneering model of multidisciplinary and translational research is among the leading comprehensive cancer centers in Europe.

VIDA aims to nurture excellent postdoctoral fellows to advance research, personalised medicine in oncology and patient health care in Europe. Following a fair, merit-based and inclusive recruitment process, the programme will hire 12 postdoctoral researchers to carry out a research project that will benefit from a stimulating and creative environment, career development and mentoring schemes, and access to high-end technologies and facilities.

Importantly, they will benefit from a tailored advanced training programme on the latest technologies, open science, gender and innovation, and from a specific mentoring scheme, with the opportunity to build valuable national and international networks with different actors in academia, hospitals, industry, editors and universities. VIDA counts on the support and collaboration of 15 associated partner organisations. The trained fellows will be equipped with skills and knowledge to tackle relevant clinical and research questions, and ultimately pursue new approaches to diagnose and treat oncology diseases.

Overall, the VIDA Programme will provide fellows skills and competences for developing a successful career in both the academic and non-academic sector and VHIO is a unique institute to bring them the possibility of contributing to improve prevention, early diagnosis, monitoring and treatment of cancer patients; key intervention areas of the Horizon Europe Mission on Cancer.

Who is involved

OrganisationCityCountryRole
Fundacio Privada Institut D'investigacio Oncologica De Vall-Hebron (vhio)BarcelonaSpainCoordinator
Deutsches Krebsforschungszentrum HeidelbergHeidelbergGermanyAssociatedpartner
Departament de Recerca i Universitats_Generalitat de CatalunyaBarcelonaSpainAssociatedpartner
Fundacio D'estudis I Recerca Oncologica (fero)BarcelonaSpainAssociatedpartner
Fundacio Barcelonabeta Brain Research CenterBarcelonaSpainAssociatedpartner
Fundacio Centre De Regulacio GenomicaBarcelonaSpainAssociatedpartner
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I SunyerBarcelonaSpainAssociatedpartner
Fundacio Hospital Universitari Vall D'hebron - Institut De RecercaBarcelonaSpainAssociatedpartner
Fundacio Institut De Bioenginyeria De CatalunyaBarcelonaSpainAssociatedpartner
Fundacio Institut De Recerca Biomedica (irb Barcelona)BarcelonaSpainAssociatedpartner
Fundacion Privada Instituto De Salud Global BarcelonaBarcelonaSpainAssociatedpartner
Fundacion Universitaria San Pablo-CeuMadridSpainAssociatedpartner
Prisma Asociacion Para La Diversidad Afectivo-Sexual Y De Genero En Ciencia Tecnologia E InnovacionPamplonaSpainAssociatedpartner
Institut Gustave RoussyVillejuifFranceAssociatedpartner
Omniscope LimitedMostaMaltaAssociatedpartner
Karolinska InstitutetStockholmSwedenAssociatedpartner
Springer Nature LimitedBasingstoke HantsUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI